Home Newsfeeds Morgan Stanley Maintains Equal-Weight on First Solar, Raises Price Target to $146

Morgan Stanley Maintains Equal-Weight on First Solar, Raises Price Target to $146

Morgan Stanley analyst Stephen Byrd maintains First Solar (NASDAQ:FSLR) with a Equal-Weight and raises the price target from $136 to $146.

byBenzinga Newsdesk

September 22, 2022

1 minute read

Morgan Stanley analyst Stephen Byrd maintains First Solar (NASDAQ:FSLR) with a Equal-Weight and raises the price target from $136 to $146.

Ra Medical’s Electrophysiology Division Announces First Use Of Catheter Precision’s LockeT Was Successfully Used In Series Of Patients

By Happy Mohamed

March 6, 9:07 AM

Catheter Precision's LockeT Successfully Used in Series of Patients FORT MILL, SC / ACCESSWIRE / March 6, 2023 / Ra Medical Systems, Inc. (RMED:NYSE/American) announced today that its wholly owned subsidiary,

RMED

News

TRxADE Health Announced That Its Subsidiary, Superlatus PD Holding Company, Entered Into A Supplier Agreement With Rainforest Distribution Corp.

By Benzinga Newsdesk

October 12, 8:09 AM

Highlights of the New Distribution Partnership:Superlatus has entered into a strategic collaboration with Rainforest, a leading Direct Store Delivery distributor serving the North Atlantic, Northeast, Midwest, and

MEDS

Here’s How Much You Would Have Made Owning Cleveland-Cliffs Stock In The Last 5 Years

By Benzinga Insights

March 1, 11:03 AM

Cleveland-Cliffs (NYSE:CLF) has outperformed the market over the past 5 years by 14.51% on an annualized basis producing…

CLF

Intercept Settles Ocaliva Litigation With Reddy’s Lab

By Vandana Singh

August 17, 10:16 AM

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) and its subsidiary Intercept Pharma Europe Limited settled patent litigation with Dr. Reddy’s Laboratories Ltd (NYSE:RDY). The litigation concerns…

Morgan Stanley Maintains Equal-Weight on First Solar, Raises Price Target to $146

Related Posts

Ra Medical’s Electrophysiology Division Announces First Use Of Catheter Precision’s LockeT Was Successfully Used In Series Of Patients

TRxADE Health Announced That Its Subsidiary, Superlatus PD Holding Company, Entered Into A Supplier Agreement With Rainforest Distribution Corp.

Here’s How Much You Would Have Made Owning Cleveland-Cliffs Stock In The Last 5 Years

Intercept Settles Ocaliva Litigation With Reddy’s Lab